KPT-330 has antitumour activity against non-small cell lung cancer

por Sun, H, Hattori, N, Chien, W, Sun, Q, Sudo, M, E-Ling, G L, Ding, L, Lim, S L, Shacham, S, Kauffman, M, Nakamaki, T, Koeffler, H P
Publicado 2014

KPT-8602, a second-generation inhibitor of XPO1-mediated nuclear export, is well tolerated and highly active against AML blasts and leukemia-initiating cells

por Etchin, J, Berezovskaya, A, Conway, A S, Galinsky, I A, Stone, R M, Baloglu, E, Senapedis, W, Landesman, Y, Kauffman, M, Shacham, S, Wang, J C Y, Look, A T
Publicado 2017

Antileukemic activity of nuclear export inhibitors that spare normal hematopoietic cells

por Etchin, J, Sun, Q, Kentsis, A, Farmer, A, Zhang, Z C, Sanda, T, Mansour, M R, Barcelo, C, McCauley, D, Kauffman, M, Shacham, S, Christie, A L, Kung, A L, Rodig, S J, Chook, Y M, Look, A T
Publicado 2013